ACHE and Alzheimer disease: Till date, only four medications including three acetylcholinesterase (AChE) inhibitors (donepezil, rivastigmine and galantamine) and N-methyl-d-aspartate (NMDA) receptor antagonist (memantine) are approved by the United States FDA for the treatment of cognitive impairment and dysfunction in the progression of AD.